Swedencare (SECARE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Achieved 10% organic net revenue growth in Q2 2024, with record sales and all segments contributing except Rest of World; strong online and pet retail channel growth, and record quarters for FlavorPal and ProDen PlaqueOff.
Completed two small brand acquisitions (HSP and Vet Worthy) and signed an agreement to acquire MedVant in Canada, expanding North American presence.
NaturVet reorganization and innovation pipeline underway, with strategic review of Amazon sales and new launches expected to impact sales from 2025.
Participation in Interzoo expo and launch of new e-commerce website in Europe, enhancing group collaboration and digital presence.
Sustainability initiatives include packaging improvements, double materiality assessment, and hiring a sustainability controller.
Financial highlights
Q2 2024 net revenue reached 630.5 MSEK, up 10% year-over-year; operational EBITDA was 140.9 MSEK (up 19%), with a 22.3% margin.
Operational gross margin improved to 57.9% (from 54.7% last year); operating cash flow was 81.2 MSEK; cash at quarter-end was 170.0 MSEK.
H1 2024 net revenue totaled 1,228 MSEK (+12%, 11% organic), operational EBITDA 279.7 MSEK (+25% YoY), margin up to 22.8%.
Net debt/EBITDA improved to 2.37, down 30% YoY, despite acquisitions and dividend payments.
Dental segment (ProDen PlaqueOff) grew 35%, with key products exceeding 40% growth.
Outlook and guidance
Expecting improved profitability in H2, with gross margin to remain at or above current levels and double-digit growth anticipated for the remainder of 2024.
NaturVet and CDMO activities expected to drive more substantial growth in 2025–2026; expansion into big box retailers planned.
Focus remains on growth, profitability, lowering debt, and strategic priorities including product launches, partnerships, and M&A.
Management targets 4 billion SEK in revenue and EBITDA margin above 30% by 2026, primarily through organic growth.
Expecting growth in Europe from Amazon transition and new product launches in H2.
Latest events from Swedencare
- Improved margins and strong sales drive a positive outlook as operational challenges ease.SECARE
Pre-close call20 Mar 2026 - Double-digit organic growth in Q4, but profitability declined due to one-off costs and disruptions.SECARE
Q4 202512 Feb 2026 - Q3 saw 9% organic growth, higher margins, and strong European and dental segment gains.SECARE
Q3 202419 Jan 2026 - Q3 2025 saw record growth, robust margins, and new targets for global expansion and profitability.SECARE
SEB Nordic Seminar presentation16 Jan 2026 - Q1 2025 delivered 7% revenue growth, strong cash flow, and key acquisitions for future expansion.SECARE
Q1 202523 Dec 2025 - Record sales and margins in 2024, with Europe and dental segments leading growth; NaturVet set for 2025 rebound.SECARE
Q4 202417 Dec 2025 - Record Q3 revenue and profitability, led by strong organic growth and U.S. retail expansion.SECARE
Q3 202514 Dec 2025 - Q2 2025 saw 3% sales growth and margin pressure, with double-digit growth expected in H2.SECARE
Q2 202516 Nov 2025